Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

  • Condition: Large cell neuroendocrine carcinoma (LCNEC) of Lungs
  • Journal: Annals of palliative medicine
  • Treatment Used: Surgery, Radiotherapy, Chemotherapy, and Immunotherapy
  • Number of Patients: 1
  • Published —
This case report describes a 64-year-old male smoker diagnosed with pulmonary large cell neuroendocrine carcinoma (LCNEC) treated with thoracoscopic radical surgery, postoperative chemotherapy with a double-drug regimen holding platinum, and then, bevacizumab, paclitaxel, and the PD-L1 checkpoint inhibitor nivolumab.
  • Condition: Treatment-Refractory Non-Small-Cell Lung Cancer (NSCLC)
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Adoptive Transfer of Zoledronate-Expanded Autologous V?9V?2 T-Cells
  • Number of Patients: 25
  • Published —
This study reported results for the use of adoptive cell therapy using zoledronate-expanded autologous V?9V?2 T-cells in patients with treatment-refractory non-small cell lung cancer (NSCLC).